RecruitingNot Applicable

Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital

Egypt600 participantsStarted 2024-06-25

Plain-language summary

* Review key history and clinical examination findings of cases with CLABSI. * Microbiological diagnosis and Culture sensitivity tests by automated Bact Alert and Vitek2c systems for CLABSI. * Determine antibiotic biogram of each organism isolated * Determine the prevalence of occurrence of Primary or secondary Blood stream infection, causing microorganism, and predisposing factors.

Who can participate

Age range1 Day

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • Patients diagnosed with sepsis based on medical history, lab investigations and clinical picture. * Both sex, and all age-groups. Exclusion Criteria: * Patients diagnosed with sepsis proved by medical history, lab investigations and clinical picture who received non-beta lactam antibiotics for the past 24 hours. * Samples proved contaminated by microbial flora will be rejected.

What they're measuring

• Microbiological diagnosis and Culture sensitivity tests

Timeframe: 6 months

Determine antibiotic biogram of each organism isolated

Timeframe: 6 months

Trial details

NCT IDNCT06458231

SponsorPort Said University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More Central Line-associated Bloodstream Infection (CLABSI) trials